OPGN Fundamental Analysis - OPGEN INC

Fundamental Rating

We assign a fundamental rating of 0 out of 10 to OPGN. OPGN was compared to 540 industry peers in the Biotechnology industry. Both the profitability and financial health of OPGN have multiple concerns. OPGN does not seem to be growing, but still is valued expensively.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year OPGN has reported negative net income.

OPGN had a negative operating cash flow in the past year.

OPGN had negative earnings in each of the past 5 years.

OPGN had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

OPGN has a worse Return On Assets (-897.50%) than 99.12% of its industry peers.

		Industry Rank	Sector Rank
ROA	-897.5%
ROE	N/A
ROIC	N/A

ROA(3y)-646.2%

ROA(5y)-422.14%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for OPGN so they could not be analyzed.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

OPGN does not have a ROIC to compare to the WACC, probably because it is not profitable.

The number of shares outstanding for OPGN has been increased compared to 1 year ago.

The number of shares outstanding for OPGN has been increased compared to 5 years ago.

OPGN has a worse debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -160.99, we must say that OPGN is in the distress zone and has some risk of bankruptcy.

OPGN's Altman-Z score of -160.99 is on the low side compared to the rest of the industry. OPGN is outperformed by 98.42% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Altman-Z	-160.99

ROIC/WACCN/A

WACC10.94%

2.3 Liquidity

A Current Ratio of 0.05 indicates that OPGN may have some problems paying its short term obligations.

Looking at the Current ratio, with a value of 0.05, OPGN is doing worse than 99.65% of the companies in the same industry.

A Quick Ratio of 0.05 indicates that OPGN may have some problems paying its short term obligations.

OPGN has a Quick ratio of 0.05. This is amonst the worse of the industry: OPGN underperforms 99.65% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	0.05
Quick Ratio	0.05

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 79.19% over the past year.

Looking at the last year, OPGN shows a very negative growth in Revenue. The Revenue has decreased by -12.39% in the last year.

OPGN shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.02% yearly.

EPS 1Y (TTM)79.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%101.64%

Revenue 1Y (TTM)-12.39%

Revenue growth 3Y-6.74%

Revenue growth 5Y3.02%

Sales Q2Q%-81.52%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next Y99.72%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-0.26%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for OPGN. In the last year negative earnings were reported.

Also next year OPGN is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

OPGN does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

OPGEN INC

NASDAQ:OPGN (8/19/2024, 8:13:00 PM)

After market: 1.85 -0.11 (-5.61%)

1.96

-0.34 (-14.78%)

Chartmill FA Rating

GICS SectorHealth Care

GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences

GICS IndustryBiotechnology

Earnings (Last)08-08 2024-08-08/amc

Earnings (Next)11-12 2024-11-12/amc

Inst Owners1.19%

Inst Owner ChangeN/A

Ins Owners1035.79%

Ins Owner Change0.01%

Market Cap2.65M

Analysts43.33

Price Target3.06 (56.12%)

Short Float %0.02%

Short Ratio0.01

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)1

Avg Revenue beat(2)-4.33%

Min Revenue beat(2)-72.52%

Max Revenue beat(2)63.87%

Revenue beat(4)1

Avg Revenue beat(4)-13.08%

Min Revenue beat(4)-72.52%

Max Revenue beat(4)63.87%

Revenue beat(8)3

Avg Revenue beat(8)-8.61%

Revenue beat(12)3

Avg Revenue beat(12)-13.34%

Revenue beat(16)5

Avg Revenue beat(16)-12.26%

PT rev (1m)0%

PT rev (3m)0%

EPS NQ rev (1m)0%

EPS NQ rev (3m)0%

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)0%

Revenue NQ rev (3m)0%

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	0.99
P/FCF	N/A
P/OCF	N/A
P/B	N/A
P/tB	N/A
EV/EBITDA	N/A

EPS(TTM)-28.18

EYN/A

EPS(NY)-0.3

Fwd EYN/A

FCF(TTM)-8.08

FCFYN/A

OCF(TTM)-7.73

OCFYN/A

SpS1.98

BVpS-7.93

TBVpS-7.93

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-897.5%
ROE	N/A
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-646.2%

ROA(5y)-422.14%

ROE(3y)N/A

ROE(5y)N/A

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score4

Asset Turnover0.9

Health

		Industry Rank	Sector Rank
Debt/Equity	N/A
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	48.53%
Cap/Sales	17.58%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	0.05
Quick Ratio	0.05
Altman-Z	-160.99

F-Score4

WACC10.94%

ROIC/WACCN/A

Cap/Depr(3y)56.59%

Cap/Depr(5y)35.76%

Cap/Sales(3y)30.71%

Cap/Sales(5y)19.23%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)79.19%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%101.64%

EPS Next Y99.72%

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-12.39%

Revenue growth 3Y-6.74%

Revenue growth 5Y3.02%

Sales Q2Q%-81.52%

Revenue Next Year-0.26%

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y42.44%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year-11.06%

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y51.99%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y51.56%

OCF growth 3YN/A

OCF growth 5YN/A

OPGEN INC (OPGN) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens